Thomas Pieber

Thomas Pieber, PhD

Scientific Advisory Board 

Dr. Pieber is the author of more than 400 scientific publications. His research focus is on endocrinology, diabetes and metabolism, obesity regenerative medicine, medical device development, nanomedicine, and nanotoxicology.

Dr. Pieber is Head of the University Clinic for Internal Medicine and Head of the Clinical Department for Endocrinology and Diabetology at the Medical University of Graz, Austria. He is Director of the HEALTH Institute – Institute for Biomedicine and Health Sciences of the Joanneum Research Forschungsgellschaft mbH in Graz.

Dr. Pieber’s group developed a novel technique called open-flow microperfusion (OFM) which is used to explore energy metabolism in adipose and muscle tissue in diabetes. His research has also addressed the role of 15-hydroxy-vitamin D in immune tolerance and autoimmunity. In a joint research effort with leading obesity centers in Europe, his group addresses the role of immune competent cells and novel pathways of chronic inflammation in obesity and diabetes

He serves as Chief Scientific Officer at CBmed GmbH, which links excellent research infrastructure, scientific expertise, medical knowledge, national and international industry partners for systematic medical biomarker research. Dr. Pieber was a post-doctoral researcher in the Department of Internal Medicine at University of Texas Southwest Medical Center.